F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-44.75M -37.13M -33.79M -31.57M -44.86M -37.52M -28.33M
Depreciation & Amortization
-77K 686K 685K 642K 1.51M 1.11M 1.11M
Stock-Based Compensation
5.66M 5.73M 6.17M 6.9M 6.84M 6.52M 5.13M
Other Working Capital
-8.16M -7.34M -792K 2.24M -2.38M 4.66M 2.22M
Other Non-Cash Items
8.55M 4.59M 3.54M 2.25M 961K 91K 1.34M
Deferred Income Tax
-569K -569K -569K -569K n/a n/a n/a
Change in Working Capital
-6.73M -5.39M -546K -4.92M -14.61M -7.28M -8.33M
Operating Cash Flow
-37.91M -32.08M -24.5M -27.27M -50.16M -37.08M -29.08M
Capital Expenditures
-272K -235K -391K -658K -1.34M -1.28M -947K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a 5M 5M 5M
Other Investing Acitivies
-83K -121K n/a 15K 9.79M 9.74M 9.81M
Investing Cash Flow
-355K -356K -391K -643K 13.46M 13.47M 13.8M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.24M 3.23M 89.98M 88.1M 102.05M 102.4M 15.41M
Financial Cash Flow
3.24M 3.23M 89.98M 88.1M 102.05M 102.4M 15.41M
Net Cash Flow
-35.48M -28.68M 65.12M 60.02M 65.52M 78.99M 132K
Free Cash Flow
-38.19M -32.32M -24.89M -27.93M -51.49M -38.35M -30.03M